Titel

Merkliste
1 Ergebnisse

FORT-1: Phase II/III Study of Rogaratinib Versus Chemothera..:

Sternberg, Cora N ; Petrylak, Daniel P ; Bellmunt, Joaquim...
Reproducció del document publicat a: https://doi.org/10.1200/JCO.21.02303. , 2022

Link: http://hdl.handle.net/2445/195774

RT Journal
T1 <Title>FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftubarcepubl:oai:diposit.ub.edu:2445_195774&Exemplar=1&LAN=DE
				
A1 Sternberg, Cora N
A1 Petrylak, Daniel P
A1 Bellmunt, Joaquim
A1 Nishiyama, Hiroyuki
A1 Necchi, Andrea
A1 Gurney, Howard
A1 Lee, Jae-Lyun
A1 van der Heijden, Michiel S
A1 Rosenbaum, Eli
A1 Penel, Nicolas
A1 Pang, See-Tong
A1 Li, Jian-Ri
A1 García del Muro Solans, Xavier
A1 Joly, Florens
A1 Papai, Zsuzsanna
A1 Bao, Weichao
A1 Ellinghaus, Peter
A1 Lu, Chengxing
A1 Sierecki, Mitchell
A1 Coppieters, Sabine
A1 Nakajima, Keiko
A1 Ishida, Tatiane Cristine
A1 Quinn, David I
PB American Society of Clinical Oncology
YR 2022
K1 Medicaments antineoplàstics
K1 Quimioteràpia
K1 Assaigs clínics de medicaments
K1 Càncer
K1 Antineoplastic agents
K1 Chemotherapy
K1 Drug testing
K1 Cancer
JF Reproducció del document publicat a: https://doi.org/10.1200/JCO.21.02303
LK http://hdl.handle.net/2445/195774
DO http://hdl.handle.net/2445/195774
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)